Riskpilot← Back to searchSign inGet full accessKRÅKERØY LEGESENTER AS
ASActiveOrg 992255676Verkstedveien 6G, 1671 KråkerøyGeneral medical practice activities · NACE 8621Est. 20085 employeeswww.krls.no
Revenue 2024
NOK 4,8M
+5% vs 2023
EBITDA margin
-3.0%
-167% vs 2023
Equity ratio
8.6%
Financial strength
Net profit 2024
NOK -214K
-241% vs 2023
| Revenue | NOK 4,8M | +5% |
| EBITDA | NOK -144K | -167% |
| Net profit | NOK -214K | -241% |
| Total assets | NOK 590K | -24% |
| Equity | NOK 51K | -81% |
| Employees | 5 | — |
Legal name
KRÅKERØY LEGESENTER AS
Org number
992255676
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
31. januar 2008
Share capital
NOK 100 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Julie aas alstedt
Company purpose
Drive allmenlege- og andre helserelaterte tjenester, herav salg, forskning, informasjon, konsulent- og servicetjenester. Investering i verdipapirer. Kjøp, salg og utleie av fast eiendom og deltagelse i annen virksomhet.
Address
Verkstedveien 6G, 1671 Kråkerøy
Email
post@krls.no
Website
www.krls.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 827 | 4 265 | 3 711 | 4 603 | 4 842 |
| Staff expenses | −1 428 | −1 644 | −1 601 | −1 699 | −1 774 |
| EBITDA | 57 | 444 | −405 | 213 | −144 |
| Depreciation & amort. | −38 | −26 | −14 | −19 | −14 |
| EBIT | 19 | 418 | −419 | 194 | −157 |
| Net financials | −0 | −0 | −0 | −0 | −1 |
| Profit before tax | 19 | 418 | −419 | 194 | −158 |
| Tax | 6 | 96 | −91 | 43 | 56 |
| Net profit | 14 | 322 | −328 | 151 | −214 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 479 | 746 | 702 | 773 | 590 |
| Equity | 119 | 441 | 113 | 265 | 51 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 360 | 305 | 589 | 509 | 539 |
| Total debt | 360 | 305 | 589 | 509 | 539 |
EBITDA margin
-3.0%
This company
15.8%
Market median
-119% vs market
20202024
Equity ratio
8.6%
This company
38.2%
Market median
-77% vs market
20202024
Return on equity
-422.9%
This company
18.4%
Market median
-2398% vs market
20202024
Net profit margin
-4.4%
This company
8.1%
Market median
-154% vs market
20202024
Asset turnover
8.21×
This company
1.12×
Market median
+633% vs market
20202024
Debt / equity
10.65×
This company
0.62×
Market median
-1618% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EP Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (2) | ||
WJ Deputy Member | Deputy Member | 2021 – 2023 |
KS Deputy Member | Deputy Member | 2021 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2024 | |
| Board of Directors | 2023 | |
| Board of Directors | 2024 | |
| Former (1) | ||
| Chairman | 2023 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 32% | 32% | 2022 | |
| Company | 25% | 25% | 2024 | |
| Company | 25% | 25% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Unimedic As
KRÅKERØY LEGESENTER AS Board members of KRÅKERØY LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Espen Paugard | Chief Executive Officer | 0 companies |
| Wai Joe Chan | Deputy Member | 0 companies |
| Kristin Skaland | Deputy Member | 0 companies |
| Svein Egil Bakkevig Hillesund | Chairman | 0 companies |
| Wai Man Chan | Board of Directors | 0 companies |
| Finn Håkon Reknes | Chairman | 0 companies |
| Sarah Henriette Brevik Drangsholt | Board of Directors | 0 companies |